42.47USD+3.21%Mkt Cap: 1.58B $P/E: —1d ago
Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products in the United States. It operates through Branded and ImprimisRx segment…
Industry Peers
Drug Manufacturers - Specialty & Genericvs Drug Manufacturers - Specialty & Generic
P/B
Pricier
1M Perf
Lower
$69.40BUSDP/E 25.2
$23.00BUSDP/E 20.0
$18.49BUSD
$16.95BUSDP/E 26.0
$15.35BUSDP/E 175.0
$15.16BUSDP/E 31.8
$12.29BUSD
$8.30BUSDP/E 21.1
$8.02BUSD
$7.22BUSDP/E 26.5
$7.09BUSDP/E 469.0
$5.52BUSDP/E 46.8
$3.54BUSDP/E 18.4
$3.48BUSDP/E 11.1
$3.22BUSDP/E 22.4
$2.66BUSDP/E 59.3
$2.70BUSD
$2.54BUSDP/E 17.6
$2.54BUSD
$2.24BUSDP/E 12.1
$1.92BUSDP/E 19.4
$2.00BUSD
$1.77BUSD
$1.88BUSDP/E 21.2
$1.90BUSD
$1.56BUSDP/E 18.4
$1.37BUSDP/E 113.1
$1.27BUSDP/E 13.5
$1.13BUSDP/E 35.6
$1.17BUSDP/E 17.6
$1.23BUSD
$1.09BUSD
$1.07BUSDP/E Infinity
$964.80MUSD
$998.26MUSDP/E 195.2
$991.60MUSD
$912.76MUSDP/E 39.9
$895.85MUSDP/E 14.4
$889.80MUSDP/E 12.2
$814.31MUSDP/E Infinity
$693.02MUSDP/E 6.8
$704.28MUSDP/E 164.2
$522.76MUSDP/E 14.7
$521.87MUSD
$488.71MUSD
$457.03MUSD
$450.66MUSD
$432.38MUSD
$323.33MUSD
$317.55MUSDP/E 43.3
$312.68MUSD
$342.71MUSD
$305.81MUSD
$304.53MUSD
$288.10MUSDP/E 51.7
$308.25MUSDP/E 9.9
$294.94MUSDP/E 15.2
$268.98MUSDP/E 9.7
$250.67MUSDP/E 47.7
$261.08MUSDP/E 13.0
$239.98MUSDP/E 53.8
$196.92MUSD
$194.94MUSD
$194.66MUSD
$182.70MUSDP/E 8.8
$178.18MUSD
$147.49MUSDP/E 18.8
$151.86MUSD
$138.58MUSD
$148.14MUSD
$125.08MUSD
$119.66MUSDP/E 18.6
$100.44MUSD
$97.09MUSD
$85.39MUSDP/E 12.3
$80.64MUSD
$72.08MUSD
$66.94MUSDP/E 56.4
$67.12MUSD
$64.16MUSD
$66.36MUSDP/E 22.8
$55.72MUSD
$60.45MUSD
$48.97MUSD
$53.46MUSD
$50.41MUSD
$42.17MUSD
$43.54MUSD
$35.03MUSDP/E Infinity
$32.51MUSD
$29.51MUSD
$25.58MUSDP/E 221.0
$23.08MUSD
$23.13MUSD
$21.73MUSD
$21.66MUSD
$18.56MUSD
$16.34MUSD
$14.36MUSDP/E 17.5
$13.58MUSD
$12.11MUSD
$11.27MUSD
$11.45MUSD
$9.80MUSD
$8.90MUSD
$7.07MUSDP/E 0.3
$6.32MUSD
$5.89MUSD
$4.95MUSDP/E 4.0
$5.64MUSDP/E Infinity
$3.29MUSDP/E 1.4
$2.15MUSD
$1.93MUSD
$1.90MUSDP/E 32.5
$1.54MUSD
$668.8KUSD
$216.1KUSDP/E 0.0
$350USD
Indicators:|
Key Statistics
Company
Market Cap1.58B $
Enterprise Value1.79B $
Revenue (TTM)268.68M $
Gross Profit204.37M $
Net Income (TTM)-5.14M $
Revenue/Share7.240 USD
Last Price42.47 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees373
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)15.87
PEG—
EV/EBITDA45.99
EV/Revenue6.65
P/S5.89
P/B55.16
EPS (TTM)-0.38
EPS (Forward)2.68
52W Range
28.5453% of range54.85
52W High54.85 USD
52W Low28.54 USD
Profitability
Gross Margin75.05%
Oper. Margin-49.95%
EBITDA Margin14.47%
Profit Margin-1.89%
ROE-9.80%
ROA-1.29%
Growth
Revenue Growth-7.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF43.86M $
CapEx (TTM)1.10M $
FCF Margin-1.88%
FCF Yield-0.32%
Net Debt204.69M $
Net Debt/EBITDA5.27
Balance Sheet
Debt/Equity4.80
Current Ratio2.48
Quick Ratio2.16
Book Value/Sh0.7700 USD
Cash/Share2.575 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:5
Split DateFeb 8, 2013
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)67.75 USD
Upside (mean)+59.5%
Target Range59.00 USD – 88.00 USD
$59.00+59.5% to mean$88.00
# Analysts8
Ownership
Shares Out.37.28M
Float28.28M
Insiders15.47%
Institutions58.85%
Short Interest
Short Ratio9.1d
Short % Float21.83%
Short % Out.19.60%
Shares Short7.31M
Short (prev mo.)6.49M
Technical
SMA 5037.16 (+14.3%)
SMA 20041.31 (+2.8%)
Beta0.28
S&P 52W Chg20.05%
Avg Vol (30d)768.11K
Avg Vol (10d)889.13K
Technical Indicators
RSI (14)64.4
MACD1.9301
MACD Signal1.5818
MACD Hist.+0.3483
BB Upper46.24 USD
BB Middle38.47 USD
BB Lower30.69 USD
BB Width40.42%
ATR (14)2.058 USD
Vol Ratio (20d)1.32x